Inmecin 25 Capsule contains Indomethacin 25 mg, a nonsteroidal anti-inflammatory drug (NSAID) primarily used to reduce inflammation, pain, and stiffness caused by various musculoskeletal disorders. Indomethacin exerts its therapeutic effect by inhibiting cyclooxygenase (COX-1 and COX-2) enzymes, leading to decreased synthesis of prostaglandins, which are mediators of inflammation and pain. This medication is indicated for the management of conditions such as rheumatoid arthritis, osteoarthritis, ankylosing spondylitis, gouty arthritis, and acute musculoskeletal injuries. Inmecin 25 Capsule is typically administered orally and should be taken with food or milk to minimize gastrointestinal irritation, a common adverse effect associated with NSAIDs. Patients should adhere to prescribed dosages and duration of therapy to reduce the risk of serious side effects, including gastrointestinal bleeding, renal impairment, and cardiovascular events. Caution is advised in individuals with a history of peptic ulcer disease, renal or hepatic dysfunction, and cardiovascular disorders. Concomitant use with other NSAIDs, anticoagulants, or corticosteroids should be avoided unless directed by a healthcare professional. Regular monitoring of renal function and blood pressure is recommended during prolonged therapy. Inmecin 25 Capsule should be used under medical supervision to ensure safe and effective treatment outcomes.